HRP20090102T3 - Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje - Google Patents

Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje

Info

Publication number
HRP20090102T3
HRP20090102T3 HR20090102T HRP20090102T HRP20090102T3 HR P20090102 T3 HRP20090102 T3 HR P20090102T3 HR 20090102 T HR20090102 T HR 20090102T HR P20090102 T HRP20090102 T HR P20090102T HR P20090102 T3 HRP20090102 T3 HR P20090102T3
Authority
HR
Croatia
Prior art keywords
ace inhibitor
procedure
preparation
mixture containing
improved pharmaceutical
Prior art date
Application number
HR20090102T
Other languages
English (en)
Croatian (hr)
Inventor
Karavas Evangelos
Koutris Efthimios
Kotzagiorgis Evangelos
Bikiaris Dimitrios
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Publication of HRP20090102T3 publication Critical patent/HRP20090102T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20090102T 2005-06-30 2006-06-29 Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje HRP20090102T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20050100332A GR1006875B (el) 2005-06-30 2005-06-30 Βελτιωμενες φαρμακευτικες συνθεσεις περιεχουσες αναστολεις του μετατρεπτικου ενζυμου αγγειοτενσινης και μεθοδοι παρασκευης αυτων.
PCT/GR2006/000033 WO2007003972A1 (en) 2005-06-30 2006-06-29 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof

Publications (1)

Publication Number Publication Date
HRP20090102T3 true HRP20090102T3 (hr) 2009-03-31

Family

ID=38043070

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090102T HRP20090102T3 (hr) 2005-06-30 2006-06-29 Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje

Country Status (12)

Country Link
EP (1) EP1906931B1 (el)
AT (1) ATE415951T1 (el)
CA (1) CA2612742C (el)
CY (1) CY1108846T1 (el)
DE (1) DE602006004057D1 (el)
DK (1) DK1906931T3 (el)
ES (1) ES2318772T3 (el)
GR (1) GR1006875B (el)
HR (1) HRP20090102T3 (el)
PL (1) PL1906931T3 (el)
PT (1) PT1906931E (el)
WO (1) WO2007003972A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN114886866A (zh) * 2022-04-08 2022-08-12 苏州中化药品工业有限公司 一种格列齐特片(ⅱ)药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
DE59905248D1 (de) * 1999-01-29 2003-05-28 Disphar Int Bv Pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
ATE415951T1 (de) 2008-12-15
WO2007003972A1 (en) 2007-01-11
DK1906931T3 (da) 2009-03-09
EP1906931B1 (en) 2008-12-03
CA2612742A1 (en) 2007-01-11
CA2612742C (en) 2010-08-03
ES2318772T3 (es) 2009-05-01
CY1108846T1 (el) 2014-07-02
EP1906931A1 (en) 2008-04-09
GR1006875B (el) 2010-07-12
PT1906931E (pt) 2009-02-12
PL1906931T3 (pl) 2009-05-29
DE602006004057D1 (de) 2009-01-15
GR20050100332A (el) 2007-01-19

Similar Documents

Publication Publication Date Title
NO20043367L (no) Oralt farmasoytisk preparat
NO20064670L (no) Galeniske formuleringer av organiske forbindelser
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
SE0302760D0 (sv) New compounds
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
FR2805817B1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
HRP20110162A8 (hr) Spojevi koji sadrže amlodipin i bisoprolol
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
WO2005117895A8 (en) Compositions comprising meloxicam
WO2005004915A3 (en) Compositions comprising meloxicam
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
EA200500672A1 (ru) Содержащие альфузозин композиции с отсроченным высвобождением
HRP20090102T3 (hr) Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение